TY - JOUR
T1 - The cytokine midkine and its receptor RPTPζ regulate b cell survival in a pathway induced by CD74
AU - Cohen, Sivan
AU - Shoshana, Or-yam
AU - Zelman-Toister, Einat
AU - Maharshak, Nitsan
AU - Binsky-Ehrenreich, Inbal
AU - Gordin, Maya
AU - Hazan-Halevy, Inbal
AU - Herishanu, Yair
AU - Shvidel, Lev
AU - Haran, Michal
AU - Leng, Lin
AU - Bucala, Richard
AU - Harroch, Sheila
AU - Shachar, Idit
N1 - Israel Science Foundation [1973/08]; Israel Cancer Association; National Institutes of Health [AR049610, AR050498, AI042310]; Alliance for Lupus ResearchThis work was supported by the Legacy Heritage Biomedical program of the Israel Science Foundation (Grant 1973/08) and by the Israel Science Foundation and the Israel Cancer Association. R. B. and L. L. were supported by the National Institutes of Health (AR049610, AR050498, AI042310) and the Alliance for Lupus Research. I.S. is the incumbent of the Dr. Morton and Ann Kleiman Professorial Chair.
PY - 2012/1/1
Y1 - 2012/1/1
N2 - Lasting B cell persistence depends on survival signals that are transduced by cell surface receptors. In this study, we describe a novel biological mechanism essential for survival and homeostasis of normal peripheral mature B cells and chronic lymphocytic leukemia cells, regulated by the heparin-binding cytokine, midkine (MK), and its proteoglycan receptor, the receptor-type tyrosine phosphatase ζ (RPTPζ). We demonstrate that MK initiates a signaling cascade leading to B cell survival by binding to RPTPζ. In mice lacking PTPRZ, the proportion and number of the mature B cell population are reduced. Our results emphasize a unique and critical function for MK signaling in the previously described MIF/CD74-induced survival pathway. Stimulation of CD74 with MIF leads to c-Met activation, resulting in elevation of MK expression in both normal mouse splenic B and chronic lymphocytic leukemia cells. Our results indicate that MK and RPTPζ are important regulators of the B cell repertoire. These findings could pave the way toward understanding the mechanisms shaping B cell survival and suggest novel therapeutic strategies based on the blockade of the MK/RPTPζ-dependent survival pathway.
AB - Lasting B cell persistence depends on survival signals that are transduced by cell surface receptors. In this study, we describe a novel biological mechanism essential for survival and homeostasis of normal peripheral mature B cells and chronic lymphocytic leukemia cells, regulated by the heparin-binding cytokine, midkine (MK), and its proteoglycan receptor, the receptor-type tyrosine phosphatase ζ (RPTPζ). We demonstrate that MK initiates a signaling cascade leading to B cell survival by binding to RPTPζ. In mice lacking PTPRZ, the proportion and number of the mature B cell population are reduced. Our results emphasize a unique and critical function for MK signaling in the previously described MIF/CD74-induced survival pathway. Stimulation of CD74 with MIF leads to c-Met activation, resulting in elevation of MK expression in both normal mouse splenic B and chronic lymphocytic leukemia cells. Our results indicate that MK and RPTPζ are important regulators of the B cell repertoire. These findings could pave the way toward understanding the mechanisms shaping B cell survival and suggest novel therapeutic strategies based on the blockade of the MK/RPTPζ-dependent survival pathway.
UR - http://www.scopus.com/inward/record.url?scp=84855382403&partnerID=8YFLogxK
U2 - https://doi.org/10.4049/jimmunol.1101468
DO - https://doi.org/10.4049/jimmunol.1101468
M3 - مقالة
C2 - 22140262
SN - 0022-1767
VL - 188
SP - 259
EP - 269
JO - Journal of Immunology
JF - Journal of Immunology
IS - 1
ER -